Sign in Subscribe
Cytology

In Situ Enzyme Immunoassay for Monitoring Hepatitis A Virus Growth in Cell Culture

Strategic Insights

— 2 min read

Researchers in Brazil have developed an in situ enzyme immunoassay that can monitor the growth of hepatitis A virus in cell culture. This assay is a significant improvement over the traditional radioimmunofocus assay, which is labor-intensive and requires the use of radioisotopes. The new assay uses a peroxidase-labeled polyclonal antibody to detect the virus, allowing for a rapid and objective assessment of infectivity.

The study, published in the Brazilian Journal of Medical and Biological Research, demonstrated the reproducibility and quantitation of the assay, with intra- and inter-assay coefficients of variation ranging from 1.9 to 3.8% and from 3.5 to 9.9%, respectively. The assay was able to detect the infectious titer of the Brazilian cell culture-adapted HAV strain (HAF-203) with a detection limit of 1.1 log TCID50/ml and a specificity of 100%.

This technique has significant implications for the diagnosis and monitoring of hepatitis A virus infections, particularly in regions where traditional assays may not be available.

Key Takeaways:

  • The in situ enzyme immunoassay developed by Brazilian researchers is a rapid and objective method for monitoring hepatitis A virus growth in cell culture.
  • The assay uses a peroxidase-labeled polyclonal antibody to detect the virus, allowing for a simple and labor-efficient assessment of infectivity.
  • The study demonstrated the reproducibility and quantitation of the assay, with intra- and inter-assay coefficients of variation ranging from 1.9 to 3.8% and from 3.5 to 9.9%, respectively.
  • The assay has a detection limit of 1.1 log TCID50/ml and a specificity of 100%.
  • The new assay represents a significant improvement over the traditional radioimmunofocus assay, which is labor-intensive and requires the use of radioisotopes.
  • This technique has significant implications for the diagnosis and monitoring of hepatitis A virus infections, particularly in regions where traditional assays may not be available.
  • The study's findings were published in the Brazilian Journal of Medical and Biological Research and demonstrate the potential for this assay to be used for diagnostic purposes.

Statistics:

  • Intra- and inter-assay coefficients of variation: 1.9-3.8% and 3.5-9.9%, respectively.
  • Detection limit: 1.1 log TCID50/ml.
  • Specificity: 100%.
  • The infectious titer of the Brazilian cell culture-adapted HAV strain (HAF-203) was 5.024 log 50% tissue culture infective dose (TCID50)/ml.

Sources:

  • Villar, L.M., et al. (2004). In situ enzyme immunoassay for titration of a Brazilian hepatitis A virus strain (HAF-203). Braz J Med Biol Res, 37(7), 1023-1027.
  • Association Bras Divulg Cientifica, Faculdade Medicina, Sala 21, 14049 Ribeirao Preto, Sao Paulo, Brazil.

Read more